DT402 trial for social & communication skills in autism
Part of Mental health clinical trials.
This trial tests an experimental drug called DT402 to see if it can improve social and communication skills in adults with autism. You may join if you are between 18 and 65, have a confirmed autism diagnosis, and have noticeable social challenges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed autism diagnosis
- You must be 18 to 65 years old
- You must have significant trouble with social interaction and communication
- No untreated eye problems that affect eye tracking
- No personal or close family history of psychosis or bipolar disorder
- No current alcohol or drug use disorder (except nicotine and caffeine)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether mild brain stimulation (TMS) over the temporoparietal junction can improve a social thinking skill called 'mentalizing' in adults with autism. You would have MRI scans, cognitive tasks, and several TMS sessions.
This trial looks at how a non-invasive brain stimulation technique may help improve social skills in people with autism. It uses a mild magnetic pulse to target brain circuits involved in social interaction.
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
This trial tests a smartphone app called NDTx-03 that may help improve social skills in teens aged 10-18 with autism or social communication disorder. It involves using the app 5 times a week for 8 weeks.
This study tests whether the drug MDMA (commonly known as ecstasy) affects levels of oxytocin (a hormone linked to social bonding) in adults with mild autism compared to healthy volunteers. The goal is to see if MDMA might help with social challenges, but it's an early research study and not a treatment for autism.
This trial tests if a mixed amphetamine medication helps teenagers with both autism and ADHD who still have significant symptoms, even if they are already on other treatments. It also includes typically developing teens as a comparison group.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.